Cargando…

Donor Lymphocyte Infusions After Allogeneic Stem Cell Transplantation in Acute Leukemia: A Survey From the Gruppo Italiano Trapianto Midollo Osseo (GITMO)

We conducted a retrospective multicenter study including pediatric and adult patients with acute leukemia (AL) who received donor lymphocyte infusions (DLIs) after allogeneic hematopoietic stem cell transplantation (HCT) between January 1, 2010 and December 31, 2015, in order to determine the effica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patriarca, Francesca, Sperotto, Alessandra, Lorentino, Francesca, Oldani, Elena, Mammoliti, Sonia, Isola, Miriam, Picardi, Alessandra, Arcese, William, Saporiti, Giorgia, Sorasio, Roberto, Mordini, Nicola, Cavattoni, Irene, Musso, Maurizio, Borghero, Carlo, Micò, Caterina, Fanin, Renato, Bruno, Benedetto, Ciceri, Fabio, Bonifazi, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593406/ https://www.ncbi.nlm.nih.gov/pubmed/33178602 http://dx.doi.org/10.3389/fonc.2020.572918

Ejemplares similares

Microbial monitoring and methods of sample collection: a GITMO survey (Gruppo Trapianto di Midollo Osseo)
por: Gori, Erica, et al.
Publicado: (2014)

Nutritional support in patients undergoing haematopoietic stem cell transplantation: a multicentre survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programmes
por: Botti, Stefano, et al.
Publicado: (2015)

Haemorrhagic cystitis in haematopoietic stem cell transplantation (HSCT): a prospective observational study of incidence and management in HSCT centres within the GITMO network (Gruppo Italiano Trapianto Midollo Osseo)
por: Gargiulo, G, et al.
Publicado: (2014)

Proposed definition of ‘poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo
por: Olivieri, A, et al.
Publicado: (2012)

The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo
por: Todisco, E, et al.
Publicado: (2013)

Outcome of Allogeneic Stem Cell Transplantation Following Reduced-Intensity Conditioninig Regimen in Patients With Idiopathic Myelofibrosis: the G.I.T.M.O. Experience
por: Patriarca, Francesca, et al.
Publicado: (2010)

V Meeting Nazionale Gruppo Italiano di Paleopatologia
Publicado: (2019)

Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01
por: Bonifazi, Francesca, et al.
Publicado: (2022)

Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study
por: Malagola, Michele, et al.
Publicado: (2023)

Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studies
por: Lambertini, Matteo, et al.
Publicado: (2023)

P1539: INFECTION-RELATED MORTALITY CLINICAL-BIOLOGICAL SCORING SYSTEM (IRM-SCORE) AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A VALIDATION STUDY IN GITMO CENTRES
por: Clerici, Daniela, et al.
Publicado: (2023)

Treatment of protruding osseo integrated dental implant
por: Buddula, Aravind, et al.
Publicado: (2010)

Osseo integrated finger prosthesis with a custom abutment
por: Thomas, Benny, et al.
Publicado: (2017)

Veno-occlusive disease nurse management: development of a dynamic monitoring tool by the GITMO nursing group
por: Botti, Stefano, et al.
Publicado: (2016)

Risk Factors and Outcome of C. difficile Infection after Hematopoietic Stem Cell Transplantation
por: Rosignoli, Chiara, et al.
Publicado: (2020)

Valutazione economica di treosulfan in pazienti sottoposti a trapianto allogenico di cellule staminali ematopoietiche
por: Bini, Chiara, et al.
Publicado: (2022)

Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey)
por: Russo, Domenico, et al.
Publicado: (2021)

Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
por: Franceschi, E, et al.
Publicado: (2007)

Delay in diagnosis of generalized miliary tuberculosis with osseo-articular involvement: a case report
por: Rodrigo, Chaturaka, et al.
Publicado: (2011)

Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study
por: Ruscitti, Piero, et al.
Publicado: (2017)

Cementless Fixation of Osteoporotic VCFs Using Titanium Mesh Implants (OsseoFix): Preliminary Results
por: Eschler, Anica, et al.
Publicado: (2014)

Bilateral Additional Slips of Triceps Brachii Forming Osseo-Musculo-Fibrous Tunnels for Ulnar Nerves
por: Swamy, RS, et al.
Publicado: (2013)

The Biomechanical Profile of an Osseo-Integrated Rectangular Block Implant: A Pilot In Vivo Strain Analysis
por: Gazelakis, Efthimios, et al.
Publicado: (2022)

Effect of Combined Application of Growth Factors and Diode Laser Bio-Stimulation on the Osseo Integration of Dental Implants
por: Arakeeb, Mohamed Ali Ali, et al.
Publicado: (2019)

Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)
por: Brandes, A A, et al.
Publicado: (2006)

Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
por: Brandes, Alba A., et al.
Publicado: (2009)

Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study
por: Ruscitti, Piero, et al.
Publicado: (2019)

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial
por: Bruna, Riccardo, et al.
Publicado: (2019)

Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell’Adulto Multiple Myeloma Working Party study
por: Musto, Pellegrino, et al.
Publicado: (2015)

Gruppo Prometeo’s volunteering experience during the COVID-19 pandemic: an example of self-organization and heutagogy
por: Bighini, Sara
Publicado: (2021)

P502: PHASE II STUDY ON VENETOCLAX PLUS DECITABINE FOR ELDERLY (≥60 <75YEARS) PATIENTS WITH NEWLY DIAGNOSED HIGH-INTERMEDIATE RISK AML ELEGIBLE FOR ALLO-SCT: MIDTERM UPDATE OF VEN-DEC GITMO STUDY
por: Russo, Domenico, et al.
Publicado: (2023)

BCR::ABL1 levels at first month after TKI discontinuation predict subsequent maintenance of treatment‐free remission: A study from the “GRUPPO TRIVENETO LMC”
por: Di Giusto, Sara, et al.
Publicado: (2022)

Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study
por: Blondeaux, Eva, et al.
Publicado: (2020)

Introducing a Novel Experimental Model for Osseo-Disintegration of Titanium Dental Implants Induced by Monobacterial Contamination: An In-Vivo Feasibility Study
por: Flörke, Christian, et al.
Publicado: (2021)

Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL)
por: Di Renzo, Nicola, et al.
Publicado: (2010)

Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG)).
por: Marsoni, S., et al.
Publicado: (1990)

Steroid treatment of acute graft-versus-host disease grade I: a randomized trial
por: Bacigalupo, Andrea, et al.
Publicado: (2017)

Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still’s disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort
por: Di Benedetto, Paola, et al.
Publicado: (2020)

Parenchymal lung disease in adult onset Still’s disease: an emergent marker of disease severity—characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients
por: Ruscitti, Piero, et al.
Publicado: (2020)

9th Congresso del Gruppo Nazionale per la Fisica dell'Atmosfera e dell'Oceano
por: Collective
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_a3lni4cggfqok5gbloo350gu22